Home NDC 62756-452 BYNFEZIA Pen
Product NDC 62756-452
11-digit product format 627560452
Labeler code 62756
Product ID 62756-452_ee3c8bae-88f0-4b76-80af-98a3e3312585
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name octreotide acetate
Dosage form INJECTION
Route SUBCUTANEOUS
Labeler Sun Pharmaceutical Industries, Inc.
Application NDA213224
Marketing category NDA
Marketing start 2025-02-24
Substance OCTREOTIDE ACETATE
Active strength 2.5 mg/mL
Pharmacologic classes Somatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 15 matching rows.
View current auxiliary records. · View the auxiliary file history.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N213224-001 BYNFEZIA PEN OCTREOTIDE ACETATE EQ 7MG BASE/2.8ML (EQ 2.5MG BASE/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2024-09-27
Orange Book patents# Current patent rows page 1 of 1 · 13 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N213224-001 BYNFEZIA PEN EQ 7MG BASE/2.8ML (EQ 2.5MG BASE/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2024-09-27 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213224-001 BYNFEZIA PEN EQ 7MG BASE/2.8ML (EQ 2.5MG BASE/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2024-09-27 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N213224-001 BYNFEZIA PEN EQ 7MG BASE/2.8ML (EQ 2.5MG BASE/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2024-09-27 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N213224-001 BYNFEZIA PEN EQ 7MG BASE/2.8ML (EQ 2.5MG BASE/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2024-09-27 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N213224-001 BYNFEZIA PEN EQ 7MG BASE/2.8ML (EQ 2.5MG BASE/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2024-09-27 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N213224-001 BYNFEZIA PEN EQ 7MG BASE/2.8ML (EQ 2.5MG BASE/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2024-09-27 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N213224-001 BYNFEZIA PEN EQ 7MG BASE/2.8ML (EQ 2.5MG BASE/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2024-09-27 2680178bc6a6…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N213224-001 BYNFEZIA PEN 7MG/2.8ML (2.5MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2024-09-27 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N213224-001 BYNFEZIA PEN 7MG/2.8ML (2.5MG/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2024-09-27 d06236e962d9…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N213224-001 BYNFEZIA PEN EQ 2.5MG BASE/ML (EQ 2.5MG BASE/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2020-01-28 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N213224-001 BYNFEZIA PEN EQ 2.5MG BASE/ML (EQ 2.5MG BASE/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2020-01-28 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N213224-001 BYNFEZIA PEN EQ 2.5MG BASE/ML (EQ 2.5MG BASE/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2020-01-28 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N213224-001 BYNFEZIA PEN EQ 2.5MG BASE/ML (EQ 2.5MG BASE/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2020-01-28 c0c555d07b60…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N213224-001 BYNFEZIA PEN EQ 7MG BASE/2.8ML (EQ 2.5MG BASE/ML) SOLUTION / SUBCUTANEOUS RLD, RS 2024-09-27 a50c72e98297…
Observed Orange Book patent history# Patent history page 1 of 3 · 107 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N213224-001 10342850 2038-05-15 Drug product 2024-10-18 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213224-001 11052196 2040-11-03 U-4007 2024-10-18 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213224-001 11052196 2040-11-03 U-4008 2024-10-18 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213224-001 11052196 2040-11-03 U-4009 2024-10-18 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213224-001 11246991 2040-11-03 U-4007 2024-10-18 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213224-001 11246991 2040-11-03 U-4008 2024-10-18 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213224-001 11246991 2040-11-03 U-4009 2024-10-18 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213224-001 11534553 2040-11-03 U-4007 2024-10-18 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213224-001 11534553 2040-11-03 U-4008 2024-10-18 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213224-001 11534553 2040-11-03 U-4009 2024-10-18 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213224-001 12350475 2041-12-29 U-4007 2025-07-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213224-001 12350475 2041-12-29 U-4008 2025-07-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N213224-001 12350475 2041-12-29 U-4009 2025-07-23 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213224-001 10342850 2038-05-15 Drug product 2024-10-18 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213224-001 11052196 2040-11-03 U-4007 2024-10-18 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213224-001 11052196 2040-11-03 U-4008 2024-10-18 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213224-001 11052196 2040-11-03 U-4009 2024-10-18 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213224-001 11246991 2040-11-03 U-4007 2024-10-18 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213224-001 11246991 2040-11-03 U-4008 2024-10-18 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213224-001 11246991 2040-11-03 U-4009 2024-10-18 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213224-001 11534553 2040-11-03 U-4007 2024-10-18 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213224-001 11534553 2040-11-03 U-4008 2024-10-18 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213224-001 11534553 2040-11-03 U-4009 2024-10-18 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213224-001 12350475 2041-12-29 U-4007 2025-07-23 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213224-001 12350475 2041-12-29 U-4008 2025-07-23 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N213224-001 12350475 2041-12-29 U-4009 2025-07-23 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N213224-001 10342850 2038-05-15 Drug product 2024-10-18 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N213224-001 11052196 2040-11-03 U-4007 2024-10-18 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N213224-001 11052196 2040-11-03 U-4008 2024-10-18 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N213224-001 11052196 2040-11-03 U-4009 2024-10-18 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N213224-001 11246991 2040-11-03 U-4007 2024-10-18 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N213224-001 11246991 2040-11-03 U-4008 2024-10-18 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N213224-001 11246991 2040-11-03 U-4009 2024-10-18 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N213224-001 11534553 2040-11-03 U-4007 2024-10-18 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N213224-001 11534553 2040-11-03 U-4008 2024-10-18 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N213224-001 11534553 2040-11-03 U-4009 2024-10-18 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N213224-001 12350475 2041-12-29 U-4007 2025-07-23 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N213224-001 12350475 2041-12-29 U-4008 2025-07-23 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N213224-001 12350475 2041-12-29 U-4009 2025-07-23 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N213224-001 10342850 2038-05-15 Drug product 2024-10-18 fd3edfee7708…
Additional Listing Data#
Finished product Yes
Brand name base BYNFEZIA Pen
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength OCTREOTIDE ACETATE 2.5 mg/mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 75R0U2568I Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2360543 Internal RxNorm lookup 2360548 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 62756-452-36 BYNFEZIA Pen 2.8 mL in 1 CARTRIDGE INJECTION 2.8 5 62756-452-36 BYNFEZIA Pen 1 in 1 CARTON INJECTION 1 5 62756-452-37 BYNFEZIA Pen 2 in 1 CARTON INJECTION 2 5 62756-452-37 BYNFEZIA Pen 2.8 mL in 1 CARTRIDGE INJECTION 2.8 5
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 62756-452 BYNFEZIA PEN (OCTREOTIDE ACETATE) INJECTION [SUN PHARMACEUTICAL INDUSTRIES, INC.] 5 Current NDC, Legacy NDC, 4 package rows 20250225_20ed4e79-ad4c-426f-859d-83790c00439b.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 62756-452-36 62756045236 1 CARTRIDGE in 1 CARTON (62756-452-36) / 2.8 mL in 1 CARTRIDGE 1 cartridge 2025-02-24 0000-00-00 No No Current 62756-452-37 62756045237 2 CARTRIDGE in 1 CARTON (62756-452-37) / 2.8 mL in 1 CARTRIDGE 2 cartridge 2025-02-24 0000-00-00 No No Current